AG
IBB icon

Ascent Group’s iShares Biotechnology ETF IBB Stock Holding History

Ascent Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$972K Sell
5,756
-153
-3% -$26.2K 0.03% 367
2025
Q4 		$997K Buy
5,909
+1,262
+27% +$205K 0.03% 372
2025
Q3 		$671K Hold
4,647
– – 0.02% 435
2025
Q2 		$588K Hold
4,647
– – 0.02% 434
2025
Q1 		$594K Sell
4,647
-131
-3% -$17.8K 0.03% 426
2024
Q4 		$632K Sell
4,778
-303
-6% -$42.6K 0.05% 341
2024
Q3 		$740K Sell
5,081
-308
-6% -$44.6K 0.06% 323
2024
Q2 		$740K Hold
5,389
– – 0.06% 310
2024
Q1 		$739K Sell
5,389
-657
-11% -$89.7K 0.07% 305
2023
Q4 		$821K Sell
6,046
-246
-4% -$30K 0.08% 281
2023
Q3 		$723K Sell
6,292
-580
-8% -$73.8K 0.08% 267
2023
Q2 		$875K Sell
6,872
-614
-8% -$79.8K 0.1% 252
2023
Q1 		$967K Sell
7,486
-313
-4% -$41K 0.1% 239
2022
Q4 		$1.02M Buy
7,799
+1
+0% +$129 0.12% 216
2022
Q3 		$1M Hold
7,798
– – 0.12% 208
2022
Q2 		$968K Hold
7,798
– – 0.12% 210
2022
Q1 		$1.02M Buy
7,798
+1
+0% +$130 0.12% 219
2021
Q4 		$1M Buy
+7,797
New +$1.21M 0.13% 220

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ascent Group's IBB Position: Q1 2026 in Review

Ascent Group reduced its iShares Biotechnology ETF (IBB) stake by 2.6% in Q1 2026, selling an estimated $26.2K and leaving 5,756 shares worth $972K. The position accounts for 0.03% of the portfolio, ranked #367.

Ascent Group first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.02M in Q4 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Ascent Group held 5,756 shares of iShares Biotechnology ETF worth $972K as of Q1 2026.
  • Ascent Group sold 153 iShares Biotechnology ETF shares in Q1 2026, an estimated $26.2K.
  • iShares Biotechnology ETF made up 0.03% of Ascent Group's portfolio in Q1 2026, its #367 holding.
  • Ascent Group first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's iShares Biotechnology ETF position peaked at $1.02M in Q4 2022.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.